Brainstorm Cell Therapeutics Stock Forecast

Sell candidate since Nov 12, 2025 Gain 6.25%

The Brainstorm Cell Therapeutics Inc. stock price gained 13.33% on the last trading day (Monday, 17th Nov 2025), rising from $0.600 to $0.680. During the last trading day the stock fluctuated 14.67% from a day low at $0.593 to a day high of $0.680. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 thousand more shares were traded than the day before. In total, 4 thousand shares were bought and sold for approximately $2.53 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.21% during the next 3 months and, with a 90% probability hold a price between $0.568 and $0.699 at the end of this 3-month period.

BCLI Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, November 14, 2025, and so far it has risen 13.33%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Brainstorm Cell Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Brainstorm Cell Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.681. On a fall, the stock will find some support from the short-term average at $0.646. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock

Brainstorm Cell Therapeutics Inc. finds support from accumulated volume at $0.670 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0870 between high and low, or 14.67%. For the last week, the stock has had daily average volatility of 9.05%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCLI) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Brainstorm Cell Therapeutics Inc. to open at $0.651, and during the day (based on 14 day Average True Range), to move between $0.651 and $0.709, which gives a possible trading interval of +/-$0.0573 (+/-8.79%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 8.79% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.690 (1.47%) than the support at $0.670 (1.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Brainstorm Cell Therapeutics Inc. stock A Buy?

Brainstorm Cell Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.482 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.651 ( 4.26%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk